THE EOF announces that, according to the information of its authorities Austria and Estoniawas trafficked illegally Intex-Sema formulation, for weight loss or increased physical activity. As informed by the Austrian authorities, the product was traded through the website https://intexpharmashop.com/shop/, of the IntexPharma company.

This product states on its packaging that it contains the pharmaceutical active substance semaglutide, which has become known from the illegal promotion of a well-known drug for the treatment of diabetes mellitus, without being approved, that is, without having been evaluated for its safety and effectiveness.

It is recalled that the purchase of prescription pharmaceutical products through websites usually leads to the supply of fake/counterfeit products. Most of the information through these websites is misleading.

Consumers/patients are requested not to purchase medicines from the internet or other unreliable sources under any circumstances, because there is a serious risk to their health.